Approval

Toludesvenlafaxine Wins Anxiety Approval

Luye Pharma's toludesvenlafaxine was approved in China for the treatment of generalized anxiety disorder. The approval appeared on the National Medical Products Administration website on November 19, under application numbers CXHS2600006 and CXHS2600007. The headline describes the approval as a first in nearly 20 years, without specifying the scope of that claim in the provided text.

Written by Gosset from public sources. Source types: News article. Sources are available to Gosset users. Log in to see them.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call